ABCB1 was enriched in EVs from various drug-resistant cancer cells after chemotherapy (Wang et al., 2019) and was associated with acquired resistance to docetaxel (Kato et al., 2015; Kharaziha et al., 2015). Here, ABCB1 is linked to cancer.